ScoreWhy is Hayat Pharmaceutical Industries Co. Ltd. ?
1
Poor Management Efficiency with a low ROCE of 13.28%
- The company has been able to generate a Return on Capital Employed (avg) of 13.28% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of -0.78% and Operating profit at -13.86% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 10.21% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of -0.78% and Operating profit at -13.86% over the last 5 years
4
Underperformed the market in the last 1 year
- The stock has generated a return of 9.59% in the last 1 year, much lower than market (Jordan General Index) returns of 37.55%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Hayat Pharmaceutical Industries Co. Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Hayat Pharmaceutical Industries Co. Ltd.
9.59%
1.45
21.08%
Jordan General Index
37.55%
3.71
10.12%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-0.78%
EBIT Growth (5y)
-13.86%
EBIT to Interest (avg)
2.85
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.14
Sales to Capital Employed (avg)
0.49
Tax Ratio
19.28%
Dividend Payout Ratio
78.19%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.72%
ROE (avg)
10.21%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
-2.83
EV to EBITDA
-1.76
EV to Capital Employed
-0.24
EV to Sales
-0.37
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
6.24%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -6.88% (YoY
CASH AND EQV(HY)
Highest at JOD 18.37 MM
OPERATING PROFIT MARGIN(Q)
Highest at 23.68 %
-2What is not working for the Company
NET PROFIT(9M)
At JOD 1.71 MM has Grown at -38.12%
Here's what is working for Hayat Pharmaceutical Industries Co. Ltd.
Operating Profit Margin
Highest at 23.68 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Cash and Eqv
Highest at JOD 18.37 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -6.88% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Hayat Pharmaceutical Industries Co. Ltd.
Net Profit
At JOD 1.71 MM has Grown at -38.12%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (JOD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
